FR

Toronto Western General Hospital is conducting a clinical research study to test a new drug for Cervical Dystonia (abnormal spasms in the neck).

The drug is currently approved for use in the USA and Canada for treating epilepsy. The purpose of this study is to test the safety and benefit in treating the symptoms of cervical dystonia.

All participants receive the active drug.

To participate you must:

                               CDR recommends Dysport Therapeutic™ be reimbursed for reducing the signs and                                                             symptoms of cervical dystonia in adults                     

English Français

DMRF Canada and DMRF are thrilled to announce that Dr. Robert Chen of Toronto Western Hospital is the recipient of the James C. Kilik Memorial Research Award for his project entitled: Modulating the functional connectivity of the cerebellum in Musician's Dystonia.

English Français

Dystonia community’s voice heard in drug reimbursement review process

October 23, 2017:   The Dystonia Medical Research Foundation (DMRF) Canada, in partnership with Allergan Canada, is pleased to announce the launch of the first-ever clinical fellowship for movement disorders, with a specialty in dystonia.

To read more please click here.